Elizabeth E. Evans - 31 Mar 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Operating Officer
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Elizabeth E. Evans
Issuer symbol
VCNX
Transactions as of
31 Mar 2023
Transactions value $
$0
Form type
4
Filing time
03 Apr 2023, 16:35:09 UTC
Previous filing
04 Apr 2022
Next filing
22 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 9.6K 31 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +40K $0.00 40K 31 Mar 2023 Common Stock 40K $0.40 Direct F5
holding VCNX Stock Option (Right to Buy) 9.61K 31 Mar 2023 Common Stock 9.61K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 8.61K 31 Mar 2023 Common Stock 8.61K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 12.4K 31 Mar 2023 Common Stock 12.4K $3.90 Direct F1
holding VCNX Stock Option (Right to Buy) 10K 31 Mar 2023 Common Stock 10K $3.82 Direct F2
holding VCNX Stock Option (Right to Buy) 8K 31 Mar 2023 Common Stock 8K $2.93 Direct F3
holding VCNX Stock Option (Right to Buy) 20K 31 Mar 2023 Common Stock 20K $1.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully exercisable as of the date of this report.
F2 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 3, 2020 grant date.
F3 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F4 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
F5 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.